Anika Therapeutics (ANIK) Tops Q3 EPS by 35c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.17 --0%
Financial Fact:
Provision for income taxes: 4.83M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Provision for income taxes: 4.83M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q3 EPS of $0.00, $0.35 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $41.5 million versus the consensus estimate of $38.27 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Tenon Medical (TNON) Misses Q2 EPS by 395c
- Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
